ctrl K

Price Alert

Aytu BioPharma Inc. (AYTU)

NASDAQ: AYTU · Real-Time Price · USD

2.21

0.02 (0.91%)

At close: Aug 15, 2025, 3:59 PM

2.24

1.36%

After-hours: Aug 15, 2025, 05:41 PM EDT

Aytu BioPharma Balance Sheet Statement

Financials in USD. Fiscal year is July - June.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Cash & Equivalents	20.01M	22.98M	19.36M	49.65M
Short-Term Investments	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	-1.38M	n/a	-10.91M
Other Long-Term Assets	2.23M	792K	766K	465K
Receivables	23.62M	28.94M	21.71M	28.18M
Inventory	12.63M	11.99M	10.85M	16.34M
Other Current Assets	5.63M	868K	633K	1.29M
Total Current Assets	61.89M	72.83M	59.93M	105.23M
Property-Plant & Equipment	1.52M	3.87M	6.3M	8.7M
Goodwill & Intangibles	52.45M	58.97M	70.63M	151.27M
Total Long-Term Assets	56.2M	63.63M	77.69M	160.43M
Total Assets	118.09M	136.46M	137.62M	265.67M
Account Payables	10.44M	13.48M	10.99M	19.25M
Deferred Revenue	n/a	46.8M	n/a	57.23M
Short-Term Debt	4.25M	85K	3.91M	24.6M
Other Current Liabilities	24.85M	49.78M	15.89M	34.76M
Total Current Liabilities	62.23M	69.02M	64.44M	109.44M
Long-Term Debt	10.88M	14.71M	14.2M	2.8M
Other Long-Term Liabilities	16.7M	13.38M	12.81M	13.23M
Total Long-Term Liabilities	28.15M	28.09M	28.87M	18.66M
Total Liabilities	90.38M	97.11M	93.31M	128.1M
Total Debt	15.13M	16.36M	18.19M	28.35M
Common Stock	1K	1K	4K	3K
Retained Earnings	-319.97M	-304.13M	-287.08M	-178.3M
Comprehensive Income	n/a	n/a	-0.00	0.00
Shareholders Equity	27.72M	39.36M	44.31M	137.57M
Total Investments	-762K	-1.38M	n/a	-10.91M